Literature DB >> 22123249

In vitro recombinants of antibiotic-resistant Chlamydia trachomatis strains have statistically more breakpoints than clinical recombinants for the same sequenced loci and exhibit selection at unexpected loci.

Tara Srinivasan1, William J Bruno, Raymond Wan, Albert Yen, Jennifer Duong, Deborah Dean.   

Abstract

Lateral gene transfer (LGT) is essential for generating between-strain genomic recombinants of Chlamydia trachomatis to facilitate the organism's evolution. Because there is no reliable laboratory-based gene transfer system for C. trachomatis, in vitro generation of recombinants from antibiotic-resistant strains is being used to study LGT. However, selection pressures imposed on in vitro recombinants likely affect statistical properties of recombination relative to naturally occurring clinical recombinants, including prevalence at particular loci. We examined multiple loci for 16 in vitro-derived recombinants of ofloxacin- and rifampin-resistant L(1) and D strains, respectively, grown with both antibiotics, and compared these with the same sequenced loci among 11 clinical recombinants. Breakpoints and recombination frequency were examined using phylogenetics, bioinformatics, and statistics. In vitro and clinical isolates clustered perfectly into two groups, without misclassification, using Ward's minimum variance based on breakpoint data. As expected, gyrA (confers ofloxacin resistance) and rpoB (confers rifampin resistance) had significantly more breakpoints among in vitro recombinants than among clinical recombinants (P < 0.0001 and P = 0.02, respectively, using the Wilcoxon rank sum test). Unexpectedly, trpA also had significantly more breakpoints for in vitro recombinants (P < 0.0001). There was also significant selection at other loci. The strongest bias was for ompA in strain D (P = 3.3 × 10(-8)). Our results indicate that the in vitro model differs statistically from natural recombination events. Additional genomic studies are needed to determine the factors responsible for the observed selection biases at unexpected loci and whether these are important for LGT to inform approaches for genetically manipulating C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123249      PMCID: PMC3264063          DOI: 10.1128/JB.06268-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  39 in total

1.  THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE.

Authors:  H J MULLER
Journal:  Mutat Res       Date:  1964-05       Impact factor: 2.433

2.  Application of phylogenetic networks in evolutionary studies.

Authors:  Daniel H Huson; David Bryant
Journal:  Mol Biol Evol       Date:  2005-10-12       Impact factor: 16.240

3.  Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots.

Authors:  João P Gomes; William J Bruno; Alexandra Nunes; Nicole Santos; Carlos Florindo; Maria J Borrego; Deborah Dean
Journal:  Genome Res       Date:  2006-11-07       Impact factor: 9.043

4.  The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome.

Authors:  Brian W Brunelle; George F Sensabaugh
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Authors:  T D Read; R C Brunham; C Shen; S R Gill; J F Heidelberg; O White; E K Hickey; J Peterson; T Utterback; K Berry; S Bass; K Linher; J Weidman; H Khouri; B Craven; C Bowman; R Dodson; M Gwinn; W Nelson; R DeBoy; J Kolonay; G McClarty; S L Salzberg; J Eisen; C M Fraser
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

Review 6.  A review on infection with Chlamydia trachomatis.

Authors:  Kaveh Manavi
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2006-08-24       Impact factor: 5.237

7.  Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.

Authors:  Shigeaki Yokoi; Mitsuru Yasuda; Shin-ichi Ito; Yoshihito Takahashi; Satoshi Ishihara; Takashi Deguchi; Shin-ichi Maeda; Yasuaki Kubota; Masayoshi Tamaki; Hideto Fukushi
Journal:  J Infect Chemother       Date:  2004-10       Impact factor: 2.211

8.  Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism.

Authors:  João P Gomes; Alexandra Nunes; William J Bruno; Maria J Borrego; Carlos Florindo; Deborah Dean
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

9.  Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis.

Authors:  Johnny C Akers; Ming Tan
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

10.  Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.

Authors:  S Dessus-Babus; C M Bébéar; A Charron; C Bébéar; B de Barbeyrac
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more
  9 in total

1.  Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner.

Authors:  Xiaofeng Bao; Asa Gylfe; Gail L Sturdevant; Zheng Gong; Shuang Xu; Harlan D Caldwell; Mikael Elofsson; Huizhou Fan
Journal:  J Bacteriol       Date:  2014-06-09       Impact factor: 3.490

2.  Culture-independent sequence analysis of Chlamydia trachomatis in urogenital specimens identifies regions of recombination and in-patient sequence mutations.

Authors:  Timothy E Putman; Robert J Suchland; John D Ivanovitch; Daniel D Rockey
Journal:  Microbiology       Date:  2013-07-10       Impact factor: 2.777

3.  Horizontal gene transfer of Chlamydia: Novel insights from tree reconciliation.

Authors:  Hyaekang Kim; Woori Kwak; Sook Hee Yoon; Dae-Kyung Kang; Heebal Kim
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

4.  Genotyping of Chlamydia abortus using multiple loci variable number of tandem repeats analysis technique.

Authors:  Sara Barati; Naghmeh Moori Bakhtiari; Leili Shokoohizadeh; Masoud Ghorbanpoor; Hassan Momtaz
Journal:  BMC Vet Res       Date:  2022-01-24       Impact factor: 2.741

5.  Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants.

Authors:  Brendan M Jeffrey; Robert J Suchland; Steven G Eriksen; Kelsi M Sandoz; Daniel D Rockey
Journal:  BMC Microbiol       Date:  2013-06-20       Impact factor: 3.605

6.  TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans.

Authors:  Mufadhal Al-Kuhlani; James Rothschild; James Rothchild; Sukumar Pal; Luis M de la Maza; Sander Ouburg; Servaas A Morré; Deborah Dean; David M Ojcius
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

7.  Chlamydiaceae Genomics Reveals Interspecies Admixture and the Recent Evolution of Chlamydia abortus Infecting Lower Mammalian Species and Humans.

Authors:  Sandeep J Joseph; Hanna Marti; Xavier Didelot; Santiago Castillo-Ramirez; Timothy D Read; Deborah Dean
Journal:  Genome Biol Evol       Date:  2015-10-27       Impact factor: 3.416

8.  [Prevalence and phylogenetic analysis of Chlamydia trachomatis in a population of women in Posadas, Misiones].

Authors:  G B Jordá; S E Hanke; J M Ramos-Rincón; J Mosmann; M L Lopéz; A C Entrocassi; C Cuffini
Journal:  Rev Esp Quimioter       Date:  2017-02-16       Impact factor: 1.553

Review 9.  The Impact of Lateral Gene Transfer in Chlamydia.

Authors:  Hanna Marti; Robert J Suchland; Daniel D Rockey
Journal:  Front Cell Infect Microbiol       Date:  2022-03-07       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.